Vimarsana
Biggest News Aggregation in the World

Page 7 - Drug Controller General News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Controller General Today - Breaking & Trending Today

Cannabis-based drug launched to treat epilepsy in children - Vimarsana News

Cannabis-based drug launched to treat epilepsy in children

Akumentis Healthcare said its new drug is effective in reducing seizures especially where conventional antiseizure medications have proven ineffective

Deanxit: The story of a drug that India has failed to ban - Vimarsana News

Deanxit: The story of a drug that India has failed to ban

The Centre banned the sale of Deanxit, a contested psychiatric drug approved without clinical data. But 10 years on, it continues to be sold by other companies.

Source: scroll.in
Glenmark launches antidiabetic drug in India - Vimarsana News

Glenmark launches antidiabetic drug in India

The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI), the company said in a statement.

Glenmark launches biosimilar of anti-diabetic drug, vows to cut down therapy cost by 70% - Vimarsana News

Glenmark launches biosimilar of anti-diabetic drug, vows to cut down therapy cost by 70%

Priced at around Rs 100 for a standard dose of 1.2 mg (per day), this will lower the cost of therapy by approximately 70 percent

Glenmark Pharma launches antidiabetic injectable - Vimarsana News

Glenmark Pharma launches antidiabetic injectable

India Business News: Glenmark Pharmaceuticals has launched the first biosimilar of the popular anti-diabetic drug, Liraglutide in India. The drug, marketed as Lirafit, is